1. Home
  2. SFNC vs VKTX Comparison

SFNC vs VKTX Comparison

Compare SFNC & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SFNC
  • VKTX
  • Stock Information
  • Founded
  • SFNC 1903
  • VKTX 2012
  • Country
  • SFNC United States
  • VKTX United States
  • Employees
  • SFNC N/A
  • VKTX N/A
  • Industry
  • SFNC Major Banks
  • VKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SFNC Finance
  • VKTX Health Care
  • Exchange
  • SFNC Nasdaq
  • VKTX Nasdaq
  • Market Cap
  • SFNC 2.8B
  • VKTX 3.0B
  • IPO Year
  • SFNC N/A
  • VKTX 2015
  • Fundamental
  • Price
  • SFNC $19.34
  • VKTX $31.60
  • Analyst Decision
  • SFNC Hold
  • VKTX Strong Buy
  • Analyst Count
  • SFNC 3
  • VKTX 12
  • Target Price
  • SFNC $23.33
  • VKTX $86.42
  • AVG Volume (30 Days)
  • SFNC 949.1K
  • VKTX 5.3M
  • Earning Date
  • SFNC 10-16-2025
  • VKTX 10-22-2025
  • Dividend Yield
  • SFNC 4.39%
  • VKTX N/A
  • EPS Growth
  • SFNC 6.86
  • VKTX N/A
  • EPS
  • SFNC 1.27
  • VKTX N/A
  • Revenue
  • SFNC $742,875,000.00
  • VKTX N/A
  • Revenue This Year
  • SFNC $26.29
  • VKTX N/A
  • Revenue Next Year
  • SFNC $8.20
  • VKTX N/A
  • P/E Ratio
  • SFNC $15.23
  • VKTX N/A
  • Revenue Growth
  • SFNC 2.18
  • VKTX N/A
  • 52 Week Low
  • SFNC $17.20
  • VKTX $18.92
  • 52 Week High
  • SFNC $25.95
  • VKTX $81.73
  • Technical
  • Relative Strength Index (RSI)
  • SFNC 41.37
  • VKTX 62.28
  • Support Level
  • SFNC $18.96
  • VKTX $25.04
  • Resistance Level
  • SFNC $19.81
  • VKTX $26.96
  • Average True Range (ATR)
  • SFNC 0.40
  • VKTX 1.67
  • MACD
  • SFNC -0.05
  • VKTX 1.00
  • Stochastic Oscillator
  • SFNC 26.92
  • VKTX 88.05

About SFNC Simmons First National Corporation

Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. The company's loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: